US Stock MarketDetailed Quotes

TCRR TCR2 Therapeutics

Watchlist
  • 1.480
  • 0.0000.00%
Close Jun 2 09:30 ET
58.11MMarket Cap-352P/E (TTM)

TCR2 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TCR2 Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

TCR2 Therapeutics Earnings Reports

  • TCR2 Therapeutics | 10-Q: Q1 2023 Earnings Report

    May 11, 2023 07:15 ET

  • TCR2 Therapeutics | 8-K: TCR 2 Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

    May 11, 2023 07:00 ET

  • TCR2 Therapeutics | 10-K: FY2022 Annual Report

    Mar 23, 2023 07:15 ET

  • TCR2 Therapeutics | 8-K: TCR 2 Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update

    Mar 23, 2023 07:00 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data